Jonathan E. Grim

723 total citations
14 papers, 528 citations indexed

About

Jonathan E. Grim is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jonathan E. Grim has authored 14 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jonathan E. Grim's work include Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Jonathan E. Grim is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Jonathan E. Grim collaborates with scholars based in United States, South Africa and Canada. Jonathan E. Grim's co-authors include Bruce E. Clurman, Jherek Swanger, Aly Karsan, Michela Noseda, Graeme W. McLean, Laura L. Smith, Linda Chang, Markus Welcker, Johan Ericsson and Michael P. Gustafson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Jonathan E. Grim

13 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan E. Grim United States	8	408	201	95	85	42	14	528
Ryan J. Davis United States	6	409 1.0×	193 1.0×	123 1.3×	73 0.9×	23 0.5×	8	510
Melissa Hector-Greene United States	8	463 1.1×	207 1.0×	82 0.9×	97 1.1×	49 1.2×	8	616
Kathryn B. Grandinetti United States	10	400 1.0×	115 0.6×	74 0.8×	91 1.1×	66 1.6×	13	534
Olivia M. Lucero United States	7	403 1.0×	172 0.9×	75 0.8×	73 0.9×	33 0.8×	13	511
Sahra Borgés United States	11	316 0.8×	141 0.7×	68 0.7×	89 1.0×	48 1.1×	13	432
Dejan Maglic United States	13	387 0.9×	328 1.6×	125 1.3×	141 1.7×	62 1.5×	14	640
Kurtis Yearsley United States	10	289 0.7×	270 1.3×	63 0.7×	129 1.5×	56 1.3×	13	500
Gitali Ganguli France	8	491 1.2×	284 1.4×	66 0.7×	125 1.5×	50 1.2×	9	627
Verónica Calvo United States	9	265 0.6×	218 1.1×	98 1.0×	167 2.0×	51 1.2×	13	513
Carrie R. Graveel United States	11	419 1.0×	201 1.0×	52 0.5×	110 1.3×	86 2.0×	21	635

Countries citing papers authored by Jonathan E. Grim

Since Specialization

Citations

This map shows the geographic impact of Jonathan E. Grim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Grim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Grim more than expected).

Fields of papers citing papers by Jonathan E. Grim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan E. Grim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Grim. The network helps show where Jonathan E. Grim may publish in the future.

Co-authorship network of co-authors of Jonathan E. Grim

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan E. Grim. A scholar is included among the top collaborators of Jonathan E. Grim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan E. Grim. Jonathan E. Grim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ku, Geoffrey Y., et al.. (2026). Zanidatamab + chemotherapy (CT) ± tislelizumab for first-line (1L) HER2-positive (HER2+) locally advanced, unresectable, or metastatic gastroesophageal adenocarcinoma (mGEA): Primary analysis from HERIZON-GEA-01.. Journal of Clinical Oncology. 44(2_suppl).

Elimova, Elena, Jaffer A. Ajani, Howard A. Burris, et al.. (2023). Zanidatamab + chemotherapy as first-line treatment for HER2-expressing metastatic gastroesophageal adenocarcinoma (mGEA).. Journal of Clinical Oncology. 41(4_suppl). 347–347. 26 indexed citations

Graf, Solomon A., Nicholas Burwick, Jonathan E. Grim, et al.. (2020). Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience. Blood Research. 55(1). 57–61. 1 indexed citations

Loeb, Keith R., Sue E. Knoblaugh, Jonathan E. Grim, et al.. (2019). Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice. Scientific Reports. 9(1). 5488–5488. 6 indexed citations

Davis, Ryan J., Mehmet Gönen, Daciana Margineantu, et al.. (2018). Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism. Proceedings of the National Academy of Sciences. 115(21). 5462–5467. 29 indexed citations

Woo, Janghee, Stacey A. Cohen, & Jonathan E. Grim. (2015). Targeted therapy in gastroesophageal cancers: past, present and future: Figure 1.. Gastroenterology report. 3(4). gov052–gov052. 14 indexed citations

Cho, Eunpi & Jonathan E. Grim. (2015). A (heat) shocking development: FBXW7 loss unleashes HSF1 to drive melanoma invasion and metastasis. Pigment Cell & Melanoma Research. 28(6). 643–644. 1 indexed citations

Welcker, Markus, Jherek Swanger, Maria T. Bengoechea-Alonso, et al.. (2013). Fbw7 dimerization determines the specificity and robustness of substrate degradation. Genes & Development. 27(23). 2531–2536. 77 indexed citations

Grim, Jonathan E., Sue E. Knoblaugh, Katherine A. Guthrie, et al.. (2012). Fbw7 and p53 Cooperatively Suppress Advanced and Chromosomally Unstable Intestinal Cancer. Molecular and Cellular Biology. 32(11). 2160–2167. 67 indexed citations

10.

Grim, Jonathan E., Michael P. Gustafson, Roli K. Hirata, et al.. (2008). Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase. The Journal of Cell Biology. 181(6). 913–920. 103 indexed citations

11.

Gustafson, Michael P., Chang Xu, Jonathan E. Grim, Bruce E. Clurman, & Beatrice S. Knudsen. (2006). Regulation of cell proliferation in a stratified culture system of epithelial cells from prostate tissue. Cell and Tissue Research. 325(2). 263–276. 6 indexed citations

12.

Grim, Jonathan E., et al.. (2006). Notch Regulation by the Fbw7/hcdc4/Sel-10 Ubiquitin Ligase.. Blood. 108(11). 1420–1420. 1 indexed citations

13.

Welcker, Markus, Amir Orian, Jonathan E. Grim, Robert N. Eisenman, & Bruce E. Clurman. (2005). A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase Regulates c-Myc and Cell Size. Current Biology. 15(24). 2285–2285. 12 indexed citations

14.

Noseda, Michela, Linda Chang, Graeme W. McLean, et al.. (2004). Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21 ^Cip1 Repression. Molecular and Cellular Biology. 24(20). 8813–8822. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact